Literature DB >> 8881666

Topical vitamin D3 (tacalcitol) for steroid-resistant prurigo.

I Katayama1, Y Miyazaki, K Nishioka.   

Abstract

A topical vitamin D3 ointment (tacalcitol) was prescribed for patients with long-lasting pruriginous lesions (four with prurigo nodularis and seven with subacute prurigo, four of whom had atopic dermatitis). Seven of 11 cases had not responded to a topical steroid ointment and even to occlusive application of the ointment. Nine of 11 cases showed a significant clinical response to this new regimen within 4 weeks. Epidermal Fc epsilon R1(+) dendritic cells were increased in number in prurigo nodularis and reduced to normal level after the therapy. Topical vitamin D3 ointment might be an alternative therapy for steroid-resistant prurigo.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8881666

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  5 in total

Review 1.  Tacalcitol.

Authors:  D C Peters; J A Balfour
Journal:  Drugs       Date:  1997-08       Impact factor: 9.546

2.  Prospective pilot trial of calcipotriene as a novel topical treatment for acute skin graft versus host disease.

Authors:  Gregory Wallace; Pooja Khandelwal; Kasiani C Myers; Emma M R Perentesis; Adam Lane; Ashley Teusink-Cross; Kristi Smiley; Stella M Davies; Sonata Jodele
Journal:  Bone Marrow Transplant       Date:  2021-01-08       Impact factor: 5.483

Review 3.  Topical therapies for pruritus.

Authors:  Sarina B Elmariah; Ethan A Lerner
Journal:  Semin Cutan Med Surg       Date:  2011-06

4.  [Linear porokeratosis with severe itch accompanied by lesional upregulation of interleukin 31, thymic stromal lymphopoietin, and periostin].

Authors:  Takashi Hashimoto; Yoshihiro Moriyama; Takahiro Satoh
Journal:  Eur J Dermatol       Date:  2021-08-26       Impact factor: 2.805

Review 5.  Itch: Epidemiology, clinical presentation, and diagnostic workup.

Authors:  Youkyung S Roh; Justin Choi; Nishadh Sutaria; Shawn G Kwatra
Journal:  J Am Acad Dermatol       Date:  2021-08-21       Impact factor: 11.527

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.